Gene · 406921
Papers4,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,581 to 1,600 of 4,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Ca2+-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases? | Acta Pharm Sin B | 2021 | 34221860 | PubTator, text mining | PubMed |
| Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management. | Aging Dis | 2021 | 34221552 | PubTator, text mining | PubMed |
| Comparison of the Clinical Value of miRNAs and Conventional Biomarkers in AMI: A Systematic Review. | Front Genet | 2021 | 34220945 | PubTator, text mining | PubMed |
| A Review on the Expression Pattern of Non-coding RNAs in Patients With Schizophrenia: With a Special Focus on Peripheral Blood as a Source of Expression Analysis. | Front Psychiatry | 2021 | 34220567 | PubTator, text mining | PubMed |
| miR-937 serves as an inflammatory inhibitor in cigarette smoke extract-induced human bronchial epithelial cells by targeting IL1B and regulating TNF-α/IL-17 signaling pathway. | Tob Induc Dis | 2021 | 34220411 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis. | BMC Cardiovasc Disord | 2021 | 34218797 | PubTator, text mining | PubMed |
| Wrong place, wrong time: Runt-related transcription factor 2/SATB2 pathway in bone development and carcinogenesis. | J Carcinog | 2021 | 34211338 | PubTator, text mining | PubMed |
| The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy. | Pharmaceutics | 2021 | 34210109 | PubTator, text mining | PubMed |
| Chemical and Biological Molecules Involved in Differentiation, Maturation, and Survival of Dopaminergic Neurons in Health and Parkinson's Disease: Physiological Aspects and Clinical Implications. | Biomedicines | 2021 | 34209807 | PubTator, text mining | PubMed |
| Description of a CSF-Enriched miRNA Panel for the Study of Neurological Diseases. | Life (Basel) | 2021 | 34206241 | PubTator, text mining | PubMed |
| Regulatory miRNA-mRNA Networks in Parkinson's Disease. | Cells | 2021 | 34204164 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Drug Resistance in Glioblastoma. | Int J Mol Sci | 2021 | 34203727 | PubTator, text mining | PubMed |
| Association of miRNA and mRNA Levels of the Clinical Onset of Multiple Sclerosis Patients. | Biology (Basel) | 2021 | 34202956 | PubTator, text mining | PubMed |
| Advanced Hydrogels as Exosome Delivery Systems for Osteogenic Differentiation of MSCs: Application in Bone Regeneration. | Int J Mol Sci | 2021 | 34201385 | PubTator, text mining | PubMed |
| BMI-1 Expression Heterogeneity in Endometriosis-Related and Non-Endometriotic Ovarian Carcinoma. | Int J Mol Sci | 2021 | 34199929 | PubTator, text mining | PubMed |
| Subcellular Localization of miRNAs and Implications in Cellular Homeostasis. | Genes (Basel) | 2021 | 34199614 | PubTator, text mining | PubMed |
| Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments. | Cancers (Basel) | 2021 | 34198989 | PubTator, text mining | PubMed |
| [Retracted] MiR‑132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3. | Int J Oncol | 2021 | 34195847 | PubTator, text mining | PubMed |
| MicroRNAs: emerging driver of cancer perineural invasion. | Cell Biosci | 2021 | 34187567 | PubTator, text mining | PubMed |
The importance of non-coding RNAs in environmental stress-related developmental brain disorders: A systematic review of evidence associated with exposure to alcohol, anesthetic drugs, nicotine, and viral infections. | Neurosci Biobehav Rev | 2021 | 34186153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/papers?page=80